ECOG-ACRIN A Phase III Trial of Rx Therapy Guided by Genomic Risk Assessment For High Anatomic Stage ER-pos/HER2-neg Breast Cancer with RS≤25 (RxFINE-Low) Adult CIRB - Late Phase Emphasis Active Available to Open